Karyopharm Therapeutics (NASDAQ:KPTI) Cut to Sell at StockNews.com
StockNews.com cut shares of Karyopharm Therapeutics (NASDAQ:KPTI – Free Report) from a hold rating to a sell rating in a report issued on Wednesday. Other equities analysts have also issued reports about the company. Barclays raised their target price on Karyopharm Therapeutics from $5.00 to $10.00 and gave the company an “overweight” rating in a […]
StockNews.com cut shares of Karyopharm Therapeutics (NASDAQ:KPTI – Free Report) from a hold rating to a sell rating in a report issued on Wednesday. Other equities analysts have also issued reports about the company. Barclays raised their target price on Karyopharm Therapeutics from $5.00 to $10.00 and gave the company an “overweight” rating in a […]
